Start Your NewsReadery Pro FREE TRIAL!

Register and verify your email address to start your NewsReadery Pro FREE TRIAL today!

Login / Register

sciencedaily.com / .sciencedaily-com-health

Top Health News -- ScienceDaily
Quick Menu features require JavaScript!
Popular News
 
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the findings are promising but not yet proof, and clinical .. ...
Scientists warn that free-living amoebae may be an underappreciated public health threat, capable of causing deadly infections and shielding other dangerous microbes from water treatment. Climate change and aging infrastructure could help these ...
Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans for the first time, finding it to be safe and well tolerated. The vaccine generated immune responses against multiple coronaviruses, including SARS-CoV-2, SARS ...
A major review of nearly 8,000 participants found that collagen supplements can improve skin health and ease osteoarthritis symptoms, especially when taken consistently over longer periods. Researchers also found modest benefits for muscle and tendon ...
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic tumors--something many scientists once thought couldn't be .. ...
A newly discovered genetic clock acts as the master timekeeper for development, orchestrating crucial bursts of gene activity throughout a worm's growth. When the clock is disrupted, development stops, offering fresh clues about how growth-related .. ...
Scientists have uncovered a surprising new way the immune system fights cancer, overturning a core belief that has guided immunology for decades. The research found that when cancer cells shut down a key immune-recognition molecule called MHC I--a .. ...
 
 
Continue
Please wait ...